Page last updated: 2024-08-24

chromic phosphate and Carcinoma, Anaplastic

chromic phosphate has been researched along with Carcinoma, Anaplastic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's3 (33.33)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarez, RD; Benda, JA; Bundy, BN; Clarke-Pearson, DL; Long, HJ; Stehman, FB; Varia, MA1
BULKLEY, GJ; COOPER, JA; O'CONOR, VJ2
Backx, C; Cash, SA; Durand, RE; Leichner, PK1
Ball, H; Bankoff, M; Bornstein, L; Goodman, A; Smith, DM1
Dempke, W; Firusian, N1
Cain, JM; Lee, RB; Peters, WA; Smith, MR; Yon, JL1
Askin, F; Currie, J; Fowler, W; Halle, J; Rosenman, J; Varia, M; Venkatraman, S; Walton, L1
Ehrlich, CE; Hornback, NB; Reddy, S; Stehman, FB; Sutton, GP1

Trials

3 trial(s) available for chromic phosphate and Carcinoma, Anaplastic

ArticleYear
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome

2003
An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases.
    Cancer, 1999, Feb-15, Volume: 85, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Chromium Compounds; Digestive System Neoplasms; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Neoplasms; Phosphates; Phosphorus Radioisotopes; Survival Rate

1999
Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary.
    Gynecologic oncology, 1992, Volume: 47, Issue:2

    Topics: Adult; Aged; Brachytherapy; Carcinoma; Chromium; Chromium Compounds; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Humans; Intestines; Life Tables; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Radiation Injuries; Reoperation; Survival Analysis

1992

Other Studies

6 other study(ies) available for chromic phosphate and Carcinoma, Anaplastic

ArticleYear
Further experiences in treatment of carcinoma of prostate with radioactive chromic phosphate and yttrium chloride.
    Transactions of the American Association of Genito-Urinary Surgeons, 1956, Volume: 48

    Topics: Carcinoma; Chromium; Chromium Compounds; Chromium Radioisotopes; Humans; Male; Phosphates; Prostatic Neoplasms; Yttrium

1956
Further experiences in treatment of carcinoma of prostate with radioactive chromic phosphate and yttrium chloride.
    The Journal of urology, 1957, Volume: 77, Issue:3

    Topics: Carcinoma; Chromium Compounds; Gold Radioisotopes; Humans; Male; Phosphates; Phosphorus; Phosphorus Radioisotopes; Prostatic Neoplasms; Yttrium

1957
Effects of injection volume on the tissue dose, dose rate, and therapeutic potential intraperitoneal 32p.
    Radiology, 1981, Volume: 141, Issue:1

    Topics: Animals; Autoradiography; Carcinoma; Cell Line; Chromium; Chromium Compounds; Cricetinae; Diaphragm; Dose-Response Relationship, Radiation; Female; Injections, Intraperitoneal; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Radiotherapy Dosage; Rats

1981
Chromic phosphate therapy in carcinoma of the ovary.
    Journal of the American College of Surgeons, 1994, Volume: 179, Issue:4

    Topics: Adult; Carcinoma; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Phosphates; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome

1994
Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
    Cancer, 1988, Mar-01, Volume: 61, Issue:5

    Topics: Carcinoma; Chromium; Chromium Compounds; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Reoperation

1988
Ovarian carcinoma: adjuvant treatment with P-32.
    Radiology, 1987, Volume: 165, Issue:1

    Topics: Brachytherapy; Carcinoma; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Posture; Radiotherapy Dosage

1987